Induction of HBsAg Decline Using an add-on Treatment of Peginterferon Alfa-2a in HBeAg-negative Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogous (PAS)
Phase of Trial: Phase IV
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Adefovir; Entecavir; Tenofovir
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms PAS
- 19 Dec 2017 Planned End Date changed from 1 Oct 2018 to 1 Oct 2019.
- 19 Dec 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 09 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Oct 2018.